3CDC. Use of influenza A/H1N1 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2009. MMWR Recomm Rep,2009,58.
4World Health Organization. New influenza A/H1 N1 virus: global epidemiological situation, June 2009 [ J ]. Wkly EpidemiolRec, 2009, 84: 249-257.
5CDC. Use of influenza A/H1 N1 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practiccs(ACIP), 2009[J]. MMWR Recomm Rep, 2009, 58.
6Commission of the European Communities. Harmonization of requirements for influenza vaccine [ S ]. EEC Document III, 1991.
7CDC. Serum cross' reactive antibody response to a novel influenza A./H1 N1 viills after vaccination with seasonal influenza vaccine [ J ]. MMWR Morb Mortal Wkly Rep, 2009, 58 : 521-524.
8GREENBERG M E, LAI M H, HARTEL G F, et al. Response after one dose of a monovalent influenza A ( H1N1 ) 2009 vaccine-preliminary report [ J ]. N Engl J Med, 2009 [ Epub ahead of print].
2Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature, 2005, 457 (7056) :209 - 214.
4Miller MA, Viboud C, Balinska M, et al. The signature features of influenza pandemics-implications for policy. N Engl J Med, 2009, 360 (25) : 2595 -2598.
5Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med, 2009, 361 (20) :1945 - 1952.
6中国疾病预防控制中心病毒病预防控制所.流感监测周报第9期[R].2010-3-7.
7四川省疾病预防控制中心.四川省扩大流感监测工作周报第28期[R].2010.
8Centers for Disease Control and Prevention.Serum cross-reactive antibody response to a novel influenza A(H1N1) virus after vaccination with seasonal influenza vaccine[J].MMWR,2009,58:521-524.
